Cleared Traditional

K041411 - MICROLIFE UPPER ARM BLOOD PRESSURE MONITOR, MODEL BP-3BTO-AP

K041411 is an FDA 510(k) clearance for MICROLIFE UPPER ARM BLOOD PRESSURE MONITOR, manufactured by Microlife Corp.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K041411 · Microlife Corp. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2004
Decision
55d
Days
Class 2
Risk

K041411 is an FDA 510(k) clearance for the MICROLIFE UPPER ARM BLOOD PRESSURE MONITOR, MODEL BP-3BTO-AP. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Microlife Corp. (Great Neck, US). The FDA issued a Cleared decision on July 21, 2004 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K041411

510(k) Number K041411 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 2004
Decision Date July 21, 2004
Days to Decision 55 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 125d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1047
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K041411.
HOMMED GENESIS PATIENT MONITOR SYSTEM WITH OPTIONS
K040799 · Hommed, LLC · Aug 2004
HOMMED SENTRY IIIB-F PATIENT MONITOR SYSTEM
K040651 · Hommed, LLC · Aug 2004
DIGITAL BLOOD PRESSURE MONITOR, MODELS SE-9000, SE-9200 AND SE-9400
K042014 · Sein Electronics Co., Ltd. · Aug 2004
NONINVASIVE BLOOD PRESSURE MONITOR, MODELS MD-880B AND MD-900T
K041789 · Meditec Co., Ltd. · Jul 2004
STABIL-O-GRAPH
K041313 · I.E.M. GmbH · Jun 2004
A & D MEDICAL UA-767BT DIGITAL BLOOD PRESSURE MONITOR
K040371 · A&D Engineering, Inc. · May 2004